CTD-T AM 12.5/80/5 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Telmisartan (80mg) + Amlodipine (5mg) + Chlorthalidone (12.5mg)
Overview CTD-T AM 12.5/80/5 Tablet
The combined medication CTD-T AM 12.5/80/5 Tablet effectively manages hypertension (high blood pressure) in cases where single-agent therapy proves insufficient. By reducing elevated blood pressure, it significantly lowers the risk of stroke and myocardial infarction. Administer this tablet with food, adhering to a consistent daily schedule as prescribed by your physician. Dosage is individualized based on your response and health status. Continuous use, as directed by your doctor, is crucial; discontinuation may increase cardiovascular event risk. This formulation includes a diuretic, potentially increasing urination; therefore, avoid taking it within four hours of bedtime. Consistent use maximizes therapeutic benefits, even during asymptomatic periods, as hypertension often presents without noticeable symptoms. Common side effects may include edema in the ankles, cephalalgia, vertigo, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your healthcare provider. Maintaining adequate hydration mitigates potential side effects such as myalgia, xerostomia, and polydipsia. Prior to commencing treatment, disclose any renal or hepatic impairment, and pregnant or breastfeeding individuals should seek medical guidance. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia ensures optimal treatment efficacy and safety.
Uses of CTD-T AM 12.5/80/5 Tablet
Elevated blood pressure
Major Benefits of CTD-T AM 12.5/80/5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-T AM 12.5/80/5 Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of CTD-T AM 12.5/80/5 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use CTD-T AM 12.5/80/5 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-T AM 12.5/80/5 Tablet should be administered with a meal.
How CTD-T AM 12.5/80/5 Tablet works:
The CTD-T AM 12.5/80/5 Tablet combines telmisartan, amlodipine, and chlorthalidone to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, reducing blood pressure. Chlorthalidone, a diuretic, further lowers blood pressure by promoting fluid excretion and, in the long term, enhancing vascular relaxation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside CTD-T AM 12.5/80/5 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using CTD-T AM 12.5/80/5 tablets during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in life-threatening emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of CTD-T AM 12.5/80/5 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of CTD-T AM 12.5/80/5 Tablet, including dizziness, headache, nausea, or fatigue, all of which can impact concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using CTD-T AM 12.5/80/5 tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with liver impairment should use CTD-T AM 12.5/80/5 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. CTD-T AM 12.5/80/5 Tablets are contraindicated for those with severe hepatic dysfunction.
What if you forget to take CTD-T AM 12.5/80/5 Tablet :
Should you forget to take your CTD-T AM 12.5/80/5 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-T AM 12.5/80/5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



